Delve into the heart of vaccine development with our three-day virtual masterclass, guided by the esteemed Dr. Tudor Arvinte. This immersive course offers a unique blend of scientific rigor and practical insights, focusing on the critical role of adjuvants in vaccine efficacy, advanced analytical techniques for vaccine characterization, and the evolution of vaccine formulations. Participants will gain a deep understanding of how adjuvants enhance immune responses, ensuring the creation of effective vaccines, and will be introduced to the latest methodologies for assessing vaccine components and their stability.
Explore the landscape of vaccine development through a historical lens, learning how innovations in formulation and high throughput technologies have revolutionized the field. This journey through time will not only highlight key advancements but also equip you with the knowledge to navigate the complex regulatory pathways essential for bringing vaccines to market. Through real-world case studies, attendees will uncover the challenges and breakthroughs in vaccine formulation, gaining insights into strategies that significantly improve vaccine potency and stability.
This masterclass is designed for professionals eager to elevate their expertise in the dynamic field of vaccine science. By combining theoretical knowledge with practical applications, it offers an unparalleled opportunity to engage with the forefront of vaccine research and development. Join us to empower your career and contribute to the future of global health through innovation in vaccine formulation.
.webp)
Unlock the Secrets of Adjuvants in Vaccine Efficacy: Learn how adjuvants boost immune responses to ensure the development of highly effective vaccines
Master Analytical Techniques: Gain expertise in cutting-edge analytical methods for characterizing vaccine components and understanding their interactions.
Dive into Real-World Vaccine Case Studies: Analyze the formulation and success stories of marketed vaccines to apply these insights to your own projects.
Explore the Evolution of Vaccine Formulations: Discover how vaccine formulations have advanced over the decades and what the future holds.
Enhance Vaccine Potency and Stability: Learn formulation strategies that have significantly improved vaccine efficacy and stability in groundbreaking case studies.
Characterize Viruses for New Therapies: Understand the role of virus characterization in developing gene therapies and immunotherapies.
Assess Vaccine Interactions with Human Plasma: Discover how vaccines interact with human plasma and blood, impacting their efficacy and safety in clinical settings.
In-depth Understanding of Adjuvant Science: Delve into the essence of how adjuvants work to amplify immune responses, differentiating between adjuvant types and their specific roles in vaccine efficacy.
Proficiency in Advanced Analytical Methods: Equip yourself with the skills to perform sophisticated analyses on vaccine components, evaluating their interaction, stability, and overall impact on the vaccine's effectiveness.
Insight into Formulation Strategy Development: Navigate the complexities of vaccine formulation, from historical evolutions to contemporary challenges, optimizing vaccine performance through strategic formulation.
Critical Evaluation of Vaccine-Biological Interactions: Acquire the ability to assess crucial interactions between vaccines and human plasma and blood crucial for predicting clinical outcomes and ensuring safety.
Forward-looking Perspectives on Vaccine Innovation: Anticipate the future of vaccine research, exploring next-generation adjuvant discoveries, novel vaccine platforms, and the transformative potential of high throughput technologies.
Practical Application through Case Studies: Apply knowledge to real-world scenarios, examining case studies that shed light on the tangible challenges and breakthroughs in vaccine formulation and development.
.png)
.png)
Tudor Arvinte, Ph.D., received his academic training in physics at the University of Jassy, Romania, and his Ph.D. in biophysics from the University of Düsseldorf, Germany. He performed his doctoral work and postdoctoral stage at the Max-Planck-Institute West Germany and held numerous research positions in Europe and the USA: at C.N.R.S., Orléans, France, at Cornell University, New York, at Texas A&M University, and at the Biophor Corporation, College Station, Texas, USA. In 1989 he joined Ciba-Geigy Pharmaceuticals in Horsham, England, and in 1994 he moved to Ciba-Geigy in Basel, Switzerland (Novartis since 1997). Until 2002 he worked as Head of Exploratory Formulation, Novartis Biotechnology Development & Production, Basel. T. Arvinte worked on the characterization and formulation of more than 200 protein and peptide drugs. Four of his protein formulations reached the market: the formulations were developed using High Throughput Analytic (HTA) and High Throughput Formulation (HTF) methods developed by T Arvinte. T. Arvinte has 90 publications, 12 book chapters, holds 15 patents on formulations of proteins, and gave more than 490 invited lectures at scientific meetings, regulatory bodies, and pharmaceutical companies. T. Arvinte was Titular Professor at the School of Pharmacy, University of Geneva, Switzerland where he is teaching a post-graduate course on “Formulation and delivery of protein biopharmaceuticals” until 2023. He co-founded Therapeomic, Inc., a biotech company focused on developing formulations for biopharmaceuticals in collaborations with pharmaceutical companies.
